Navigation Links
Ben-Gurion University of the Negev professor awarded the 2010 Elkeles Prize for Cancer Research
Date:8/8/2010

BEER-SHEVA, ISRAEL, August 9, 2010 Ben-Gurion University of the Negev (BGU) Professor Ron N. Apte has been awarded the 2010 Samuel and Paula Elkeles Prize for Outstanding Scientist in the Field of Medicine.

Professor Apte is chairman of the Shraga Segal Department of Microbiology and Immunology and vice dean of the Basic Sciences division in the BGU Faculty of Health Sciences. He is also the Irving Sklar Chair in Endocrinology and Cancer and a member of the National Institute for Biotechnology in the Negev.

Apte's major field of research involves inflammation in malignant processes. Approximately 15 percent of cancers are connected to inflammation, which typically result in organs where chronic inflammation has occurred. For example, patients with Inflammatory Bowel Disease (IBD) are more prone to cancer than the general population.

The pioneering studies of Apte's group demonstrated the feasibility of intervening in malignant process by neutralizing inflammatory components in the "normal" microenvironment of a tumor. They also detailed the basic concepts underlying such treatment.

Inflammatory cells affect proliferation and invasiveness of malignant cells through the secretion of cytokines, which include Interleukin-1 (IL-1), the molecule that has been studied for years by Apte's group. The group has demonstrated the involvement of IL-1-mediated inflammation in tumor invasiveness and metastasis. IL-1 causes tumor expansion because it suppresses the immune system and nourishes a tumor's blood vessels. Apte's group treated tumor-bearing mice with a specific inhibitor of IL-1, known as the IL-1 receptor antagonist (IL-Ra), and succeeded in weakening the tumor's invasiveness.

IL-Ra, in its generic form Anakirna, is a medication that efficiently alleviates symptoms of patients suffering from rheumatoid arthritis, a chronic inflammatory disease.

Apte joined the BGU Faculty of Sciences in 1981 and has served two full terms as vice dean, as the vice dean of Student Affairs, and as the vice dean for Graduate Studies. Since 2008, he has been the vice dean for Basic Science Affairs.

Apte has been a member of the board of the European Cytokine Society since 1989 and has served on the board of its journal, "The European Cytokine Network". He was also president of the Israel Immunological Society from 1996 to 1998.

Apte has served as a charter member of the International Cancer Microenvironment Society (ICMS) and as an editorial board member of its journal "Cancer Microenvironment". Prof. Apte has published more than 80 papers in the fields of immunology, tumor biology and cytokine biology.


'/>"/>

Contact: Andrew Lavin
andrewlavin@alavin.com
516-353-2505
American Associates, Ben-Gurion University of the Negev
Source:Eurekalert

Related biology news :

1. Ben-Gurion University of the Negev researchers identify risks of hypertension in young adults
2. FDA approves trial for type 1 diabetes treatment by Ben-Gurion U. and U. Colorado
3. Ben-Gurion U researchers isolate microalgal strain that could reduce cholesterol
4. Uniform method to interpret autism spectrum disorders is defined at Ben-Gurion University
5. Anti-inflammatory drugs (coxibs) interfere with aspirins clotting ability -- Ben-Gurion U.
6. Heartburn drugs deemed safe for fetuses according to Ben-Gurion University researchers
7. Ben-Gurion University Alzheimers researcher demonstrates specific immune response to vaccine
8. Ben-Gurion University of the Negev technology being developed for use in Jordan desalination plant
9. Ben-Gurion U. developing new computer techniques to analyze historic Hebrew and Arabic documents
10. 1 in 6 health workers wont report in flu pandemic -- study by Ben-Gurion U. researchers
11. Ben-Gurion U. researchers reveal connection between cancer and human evolution
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2017)... YORK , March 30, 2017 Trends, ... type (physiological and behavioral), by technology (fingerprint, AFIS, iris ... voice recognition, and others), by end use industry (government ... and immigration, financial and banking, and others), and by ... Europe , Asia Pacific , ...
(Date:3/27/2017)... ROCKVILLE CENTRE, N.Y. , March 27, 2017 ... by Healthcare Information and Management Systems Society (HIMSS) ... Analytics Outpatient EMR Adoption Model sm . In ... top 12% of U.S. hospitals using an electronic ... recognized CHS for its high level of EMR ...
(Date:3/23/2017)... 23, 2017 The report "Gesture Recognition and Touchless Sensing ... Geography - Global Forecast to 2022", published by MarketsandMarkets, the market is expected ... 29.63% between 2017 and 2022. Continue Reading ... ... ...
Breaking Biology News(10 mins):
(Date:5/11/2017)... , May 11, 2017   BioLife Solutions , Inc. ... marketer of proprietary clinical grade cell and tissue hypothermic ... the "Company"), today reported operational highlights and financial results for ... media product sales reached a new high of $2.4 million ... over the same period in 2016. Revenue growth was driven ...
(Date:5/11/2017)... Linda, Ca (PRWEB) , ... May 11, 2017 ... ... and primary rodent neurons both are excellent resources for disease modeling and drug ... and further differentiated into mature neurons for various applications, however, these often contain ...
(Date:5/10/2017)... ... May 10, 2017 , ... Shimadzu Scientific Instruments (SSI) ... host of technologically advanced features, resulting in a modernized instrument that improves user ... a higher return on investment. , Engineered with the analyst in mind, ...
(Date:5/10/2017)... ... May 10, 2017 , ... ... Center as VP Corporate Development. Cervantes brings over 20 years’ experience in ... and academic research environments. , In this newly created position at the ...
Breaking Biology Technology: